CLLS(Cellectis S.A.) · 财务报表

CLLS(Cellectis S.A.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$30.35M$19.17M$755.00K$41.51M$72.95M
毛利润$28.50M$17.40M$18.00K$41.51M$72.95M
营业利润−$103.48M−$89.67M−$97.30M−$59.55M−$33.08M
净利润−$114.20M−$106.14M−$101.06M−$36.76M−$67.59M
经营现金流−$104.56M−$87.44M−$24.75M$22.99M−$39.40M
自由现金流−$123.11M−$89.88M−$25.82M$20.41M−$41.76M
摊薄每股收益$-2.55$-2.33$-1.77$-0.41$-0.67

Cellectis S.A. CLLS